These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35263746)

  • 21. High-Volume Hemodiafiltration with Step-Down Approach versus Standard-of-Care Continuous Renal Replacement Therapy Approach in Critically Ill Burn Patients.
    Khandelwal A; Yerigeri K; Lou R; Raina R
    Blood Purif; 2023; 52(4):341-344. PubMed ID: 36516796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes.
    Khajehdehi P; Jamal JA; Bastani B
    Clin Nephrol; 2000 Oct; 54(4):351-5. PubMed ID: 11076113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)--a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project.
    Wald R; Friedrich JO; Bagshaw SM; Burns KE; Garg AX; Hladunewich MA; House AA; Lapinsky S; Klein D; Pannu NI; Pope K; Richardson RM; Thorpe K; Adhikari NK
    Crit Care; 2012 Oct; 16(5):R205. PubMed ID: 23095370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury.
    Mariano F; Mella A; Rumbolo F; Holló Z; Bergamo D; Congiu G; Mengozzi G; Berardino M; Stella M; Biancone L
    Blood Purif; 2023; 52(5):446-454. PubMed ID: 36882012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies.
    Mariano F; Leporati M; Carignano P; Stella M; Vincenti M; Biancone L
    J Nephrol; 2015 Oct; 28(5):623-31. PubMed ID: 25249467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of Micafungin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis With High Cutoff Membranes.
    Tenorio-Cañamás T; Grau S; Luque S; Fortún J; Liaño F; Roberts JA
    Ther Drug Monit; 2019 Jun; 41(3):376-382. PubMed ID: 30633087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clinical and Laboratory Efficacy of HA 330 Treatment Combined with Continuous Renal Replacement Therapy in Septic Shock Patients: A Case Series.
    Onuk S; Akin AK; Sari A; Gundogan K; Baskol G; Dogru K; Sungur M
    Blood Purif; 2023; 52(2):140-147. PubMed ID: 36634624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in CVVH vs. CVVHDF in the management of sepsis-induced acute kidney injury in critically ill patients.
    Premuzic V; Basic-Jukic N; Jelakovic B; Kes P
    J Artif Organs; 2017 Dec; 20(4):326-334. PubMed ID: 28676904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.
    Kade G; Literacki S; Rzeszotarska A; Niemczyk S; Lubas A
    Blood Purif; 2018; 46(2):153-159. PubMed ID: 29705804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment.
    Quinto BM; Iizuka IJ; Monte JC; Santos BF; Pereira V; Durão MS; Dalboni MA; Cendoroglo M; Santos OF; Batista MC
    Cytokine; 2015 Feb; 71(2):255-60. PubMed ID: 25461406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial.
    Weidhase L; Haussig E; Haussig S; Kaiser T; de Fallois J; Petros S
    PLoS One; 2019; 14(4):e0215823. PubMed ID: 31026303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Production, Efficacy, and Safety of Machine-Generated Bicarbonate Solution for Continuous Venovenous Hemodialysis (CVVHD): The Cleveland Clinic Method.
    Taliercio JJ; Nakhoul G; Vachharajani TJ; Layne M; Sedor J; Thomas G; Mehdi A; Heyka R; Demirjian S
    Kidney Med; 2021; 3(3):353-359.e1. PubMed ID: 34136781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and safety of combined cytokine adsorption and continuous veno-venous hemodialysis with regional citrate anticoagulation in patients with septic shock.
    Dimski T; Brandenburger T; Slowinski T; Kindgen-Milles D
    Int J Artif Organs; 2020 Jan; 43(1):10-16. PubMed ID: 31379256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Renal Replacement Therapy.
    Kaçar CK; Uzundere O; Kandemir D; Yektaş A
    Blood Purif; 2020; 49(4):448-456. PubMed ID: 31991412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coupled-plasma filtration and adsorption for severe burn patients with septic shock and acute kidney injury treated with renal replacement therapy.
    Mariano F; Hollo' Z; Depetris N; Malvasio V; Mella A; Bergamo D; Pensa A; Berardino M; Stella M; Biancone L
    Burns; 2020 Feb; 46(1):190-198. PubMed ID: 31787473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of filter life span and solute removal during continuous renal replacement therapy: convection versus diffusion - A randomized controlled trial.
    Xu Q; Jiang B; Li J; Lu W; Li J
    Ther Apher Dial; 2022 Oct; 26(5):1030-1039. PubMed ID: 34967496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.
    Abe M; Okada K; Suzuki M; Nagura C; Ishihara Y; Fujii Y; Ikeda K; Kaizu K; Matsumoto K
    Artif Organs; 2010 Apr; 34(4):331-8. PubMed ID: 20420616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Medium Cutoff Membranes on Pro-Inflammatory Cytokine and Oxidative Marker Levels in Patients with Sepsis Who Developed Acute Kidney Injury.
    Comoglu M; Dede F; Yenigun EC; Topcuoglu C; Inan O; Sahiner ES; Ates I
    Blood Purif; 2022; 51(9):772-779. PubMed ID: 34814149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.
    Hellman T; Uusalo P; Järvisalo MJ
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):778-784. PubMed ID: 33595109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.